Selective Blockade of the Sigma 1 Receptor Has Beneficial Effects on Both Acute and Chronic Oxaliplatin-Induced Peripheral Neuropathy

This publication has 18 references indexed in Scilit:

• Oxaliplatin-Induced Peripheral Neuropathy and Identification of Unique Severity Groups in Colorectal Cancer
  Journal of Pain and Symptom Management, 2017
• The Sigma-1 Receptor as a Pluripotent Modulator in Living Systems
  Trends in Pharmacological Sciences, 2016
• Chemotherapy-induced peripheral neurotoxicity
  Current Opinion in Neurology, 2015
• Investigational sigma-1 receptor antagonists for the treatment of pain
  Expert Opinion on Investigational Drugs, 2015
• Chemotherapy dose reduction due to chemotherapy induced peripheral neuropathy in breast cancer patients receiving chemotherapy in the neoadjuvant or adjuvant settings: a single-center experience
  SpringerPlus, 2014
• Genetic Inactivation and Pharmacological Blockade of Sigma-1 Receptors Prevent Paclitaxel-Induced Sensory-Nerve Mitochondrial Abnormalities and Neuropathic Pain in Mice
  Molecular Pain, 2014
• Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
  JAMA, 2013
• Deconstructing the Neuropathic Pain Phenotype to Reveal Neural Mechanisms
  Neuron, 2012
• Multimodal Assessment of Painful Peripheral Neuropathy Induced by Chronic Oxaliplatin-Based Chemotherapy in Mice
  Molecular Pain, 2011
• Oxaliplatin-safety profile: neurotoxicity
  Seminars in Oncology, 2003